FindTrial
Sign In

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in Cardiovascular Disease: A Meta-analysis

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in Cardiovascular Disease: A Meta-analysis - Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in Cardiovascular Disease: A Meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049627
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Literature obtained by the following search formula will be considered. #1 (extracellular volume fraction OR extracellular volume OR ECV) #2 (computed tomography OR CT OR cardiac computed tomography OR contrast-enhanced computed tomography) #3 (myocardium OR myocardial OR cardiac) #4 #1 AND #2 AND #3

Exclusion criteria

Exclusion criteria: We will exclude references that are unbeatable for our analysis, such as those with missing data.

Design outcomes

Primary

MeasureTime frame
Electronic database searches will be PubMed, Web of Science Core Collection, Cochrane advanced search, and EMBASE. Compare CT-ECV between cardiovascular disease and controls. We will also examine differences in CT-ECV between AS and CA, since preoperative differentiation between aortic stenosis (AS) and cardiac amyloidosis (CA) is important in transcatheter aortic valve replacement.—

Countries

Japan

Contacts

Public ContactShingo Kato

Yokohama City University Department of Diagnostic Radiology

shingo.m12226@gmail.com0457872800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026